GILD Financial Facts
Cost of goods sold: 1.13BShares used in per share calculation - basic: 1.32B
See Full Income Statement
Cash and cash equivalents: 9.81B
Short-term marketable securities: 2.46B
See Full Balance Sheet
Gilead Sciences Inc. (GILD) Earnings
|
Expand Research on GILD
| Next EPS Date | 4/25/24 | EPS Growth Rate | +16.1% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.9% | Revenue Growth Rate | -0.6% |
| Average % Move 1-Wk after EPS | -3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $1.59 | N/A | N/A | $6.36B | = | N/A | N/A | ||
| 2/6/24 | Q423 | $1.72 | $1.76 | -$0.04 | $7.1B | $7.1B | = |  | | Details | |
| 11/7/23 | Q323 | $2.29 | $1.91 | +$0.38 | $7.1B | $6.81B | = | | | Details | |
| 8/3/23 | Q223 | $1.34 | $1.65 | -$0.31 | $6.6B | $6.45B | = | | | Details | |
| 4/27/23 | Q123 | $1.37 | $1.53 | -$0.16 | $6.4B | $6.31B | = | | | Details | |
| 2/2/23 | Q422 | $1.67 | $1.50 | +$0.17 | $7.4B | $6.66B | = | | | Details | |
| 10/27/22 | Q322 | $1.90 | $1.52 | +$0.38 | $7B | $6.13B | = | | | Details | |
| 8/2/22 | Q222 | $1.58 | $1.52 | +$0.06 | $6.3B | $5.86B | = | | | Details |
